This study links rare genetic variants to type 2 diabetes risk, emphasizing their role in monogenic diabetes and potential ...

A study of almost 13,000 adults with Type 2 diabetes and high systolic blood pressure assessed if a more intensive treatment ...

Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...

Amidst discrepant SPRINT and ACCORD data, this study confirms the benefits seen in nondiabetics, Shawna Nesbitt says.

The cardiovascular outcome benefit of a tighter systolic blood pressure target was affirmed in patients with type 2 diabetes ...

RFK Jr.'s nomination as head of Department of Health and Human Services spotlights unorthodox health views, but scientists ...

More people living in rural areas of the United States are dying from heart attacks, strokes and other cardiovascular ...

Dietitians often field this question, especially in a diet culture that demonizes sweet stuff as a whole. Here’s what they ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...